56 Days
Source:
أخبار 24
_1777294237270_124456903.png&w=64&q=75){kind=small}
Source: أخبار 24
56 Daysأخبار 24
Source: أخبار 24
56 DaysReady to play
Ready to play
The Local Content and Government Procurement Authority signed three agreements to localize the manufacturing of biotech products in Saudi Arabia, including semaglutide, avapritinib, and etcheskinumab, during the Riyadh Global Biotechnology Summit. The agreements aim to boost local content and increase innovation in the pharmaceutical industry, with expectations to contribute approximately 4.4 billion riyals to the gross domestic product and create more than 800 new jobs.
Notice: This Is an AI-Generated Summary
Comments (0)